|
|
1.
|
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. MedStar authors:
Year: 2018
Citation: - The Lancet Diabetes & Endocrinology. 6(4):275-286, 2018 04.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Andreassen C, Aroda VR, Lingvay I, Ludemann J, Navarria A, Pratley RE, SUSTAIN 7 investigators, Viljoen A
|
|
|
2.
|
Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept. MedStar authors:
Year: 2021
Citation: - BMC Cardiovascular Disorders. 21(1):201, 2021 04 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abbate A, Beutler A, Cella D, Cremer P, Ertel A, Fang F, Klein A, Klooster B, LeWinter MM, Lin D, Litcher-Kelly L, Luis SA, Magestro M, Paolini JF
|
